Seeking Alpha

Hill-Rom Holdings, Inc. (HRC)

  • Jan. 23, 2014, 12:47 PM
    | Comment!
  • Feb. 6, 2013, 12:35 PM
    Hill-Rom Holdings (HRC +3%) moves up on an upgrade to Conviction-Buy at Goldman Sachs. Goldman says the hospital bed cycle has bottomed and they see potential for a rebound in the second half. The firm adds that FQ1 results were solid, and cash flow growth should support higher levels of share repurchases. The firm raises its price target on the stock to $41 from $40.
    | 1 Comment
  • Jan. 24, 2013, 11:22 AM
    Hill-Rom (HRC +4%) moves up this morning after its FQ1 earnings beat estimates late yesterday. Net profit fell 27% Y/Y however, as the hospital-bed supplier recorded significantly higher costs, masking a 12% jump in overall sales. International sales were particularly strong, increasing 39% to $134.7M. The company guides its FQ2 below analysts' estimates however, largely on charges. It now expects to earn $0.48 to $0.50 per share on revenue growth of 4% to 5%. Analysts are looking for $0.52 on 9% growth.
    | Comment!
  • Oct. 25, 2012, 12:34 PM
    Hill-Rom (HRC +6%) trades up after its FQ4 earnings beat estimates late yesterday. Net earnings fell 38% Y/Y however, as the hospital-bed supplier booked higher expenses and reclassified its North America businesses. For FY13 the company projects earnings to be around $2.12 to $2.22 per share on revenue growth of 7% to 8%. Analysts were looking for $2.17 and 3% growth, respectively.
    | Comment!
  • Oct. 24, 2012, 5:18 PM
    Hill-Rom (HRC): FQ4 EPS of $0.56 beats by $0.01. Revenue of $432M (flat% Y/Y) beats by $14M. Shares +1.6% AH. (PR)
    | Comment!
  • Aug. 15, 2012, 3:23 PM
    Hill-Rom (HRC +5.8%) trade up today after Kinetic Concepts sold its competing Therapeutic Support Systems unit to Getinge AB for around $275M. The valuation of the acquisition, along with speculation that HRC could become a takeover target appears to be what's driving the move.
    | Comment!
  • Jan. 11, 2012, 4:04 PM
    Medical equipment maker Hill-Rom (HRC -11.6%) tumbles after warning it expects FQ1 revenue of $381M (+2% Y/Y) and EPS of $0.52-$0.53, below a consensus of $393.1M and $0.56. Moreover, citing macro weakness, Hill-Rom now expects FY12 (ends in September) revenue growth of just 2%-3% and EPS of $2.45-$2.50, below a consensus of 4.8% growth and $2.52. (yesterday)
    | Comment!
  • Jan. 10, 2012, 2:29 PM
    Hill-Rom Holdings (HRC +2.3%) gains after S&P ups credit rating a notch further into investment-grade territory, saying it expects sustained sales growth and solid margins from the hospital-bed supplier.
    | Comment!
  • Jul. 28, 2011, 11:27 AM
    Hill-Rom Holdings (HRC -17%) FQ3 profits plunge 95% as its bottom line is hit by lower margins resulting from an unfavorable product mix, higher material costs and a $30M charge related to a potential legal settlement.
    | Comment!
Visit Seeking Alpha's
HRC vs. ETF Alternatives
Company Description
Hill-Rom Holdings Inc is engaged in selling and renting patient support and near-patient technologies and services, and health information technology solutions in the U.S. and Canada.